RR

Rohini Ramesh Malwade

Active Director Director DIN 08257366
DIN 08257366 First appointment Oct 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Rohini Ramesh Malwade

Data last updated:

Rohini Ramesh Malwade is a Director at Sukarta Healthcare Private Limited (since 2018). The company operates in Business Services.

DIN 08257366
Primary Designation Director
Industry Business Services
First Appointment 15 Oct 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sukarta Healthcare Private Limited U74999PN2018PTC179590
Director15 Oct 20182018Active

Board colleagues of Rohini Ramesh Malwade

NameDINCompanyDesignation
Chandrakant Rajaram Kale08257365Sukarta Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sukarta Healthcare Private Limited
Premium access

Shareholding and investment profile for Rohini Ramesh Malwade

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rohini Ramesh Malwade

Rohini Ramesh Malwade currently holds 1 directorship: Sukarta Healthcare Private Limited (Director, since 15 Oct 2018).

Rohini Ramesh Malwade was first appointed on 15 Oct 2018 as Director at Sukarta Healthcare Private Limited.

The current boards of Rohini Ramesh Malwade's companies include Chandrakant Rajaram Kale (Sukarta Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available